Jp. Salmon et al., Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation, TRANSFUSION, 39(8), 1999, pp. 824-827
BACKGROUND: Bone marrow transplantation with minor ABO incompatibility may
be followed by moderate delayed hemolysis of the recipient's red cells by d
onor-derived ABO antibodies. This reaction may be more severe after transpl
antation of peripheral blood progenitor cells (PBPCs).
CASE REPORT: A 16-year-old boy underwent an allogeneic PBPC transplant from
his HLA-mismatched mother as treatment for acute myeloblastic leukemia tha
t had proved resistant to induction chemotherapy. Transfusion of the unmani
pulated PBPCs proceeded without any complication, despite the difference in
ABO blood group (donor, O Rh-positive; recipient, A Rh-positive). On Day 7
, a rapid drop in hemoglobin to 4 g per dL was observed, which was attribut
ed to a massive hemolysis. All the recipient's group A red cells were destr
oyed within 36 hours. This delayed and rapidly progressive hemolytic anemia
was not associated with the transfusion of the donor's plasma. Rather, the
anti-A titer increased in parallel with marrow recovery, which suggested a
n active synthesis of these antibodies by immunocompetent cells from the do
nor against the recipient's red cells. The mother's anti-A titer was retros
pectively found to be 2048. Her unusually high titer is probably due to pri
or sensitization during pregnancies. On Day 12, the patient developed grade
IV graft-versus-host disease, which proved resistant to all treatments ins
tituted and led to his death on Day 35.
CONCLUSION: PBPC transplantation with minor ABO incompatibility may be asso
ciated with significant risk of massive delayed hemolysis.